Astronics ATRO 深 沪
等待开盘 12-16 09:30:00 美东时间
53.03
-1.370
-2.52%
华盛通- 最 高55.65
- 今 开54.67
- 成交量 23.99万股
- 最 低 52.75
- 昨 收 54.40
- 总市值 18.78亿
- 52周最高 55.65
- 市盈率 静 --
- 换手率 0.68%
- 52周最低 15.43
- 委 比 -55.98%
- 总股本 3540.62万
- 历史最高 55.65
- 量 比 0.61
- 振 幅 5.33%
- 历史最低 -16.3257
- 每 手 1
- 风险率 11.48%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多This Autodesk Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
11-27 00:45
TD Cowen Initiates Coverage On Astronics with Buy Rating, Announces Price Target of $65
TD Cowen analyst Gautam Khanna initiates coverage on Astronics (NASDAQ:ATRO) with a Buy rating and announces Price Target of $65.
11-26 19:18
Astronics Corporation Reports Strong Aerospace Growth
Astronics ( ($ATRO) ) has released its Q3 earnings. Here is a breakdown of the ...
11-05 12:28
Astronics shares are trading higher after the company reported better-than-expected Q3 EPS results.
Astronics shares are trading higher after the company reported better-than-expe...
11-05 06:15
Astronics Narrows FY2025 Sales Guidance from $840.000M-$860.000M to $847.000M-$857.000M vs $851.609M Est
Astronics (NASDAQ:ATRO) narrows FY2025 sales outlook from $840.000 million-$860.000 million to $847.000 million-$857.000 million vs $851.609 million estimate.
11-05 05:31
Astronics Q3 Adj. EPS $0.49 Beats $0.42 Estimate, Sales $211.447M Miss $212.075M Estimate
Astronics (NASDAQ:ATRO) reported quarterly earnings of $0.49 per share which beat the analyst consensus estimate of $0.42 by 17.51 percent. This is a 40 percent increase over earnings of $0.35 per share from the same
11-05 05:29
Earnings Scheduled For November 4, 2025
Companies Reporting Before The Bell • Sequans Communications (NYSE:SQNS) is lik...
11-04 19:12
Earnings Preview For V2X
V2X (NYSE:VVX) is preparing to release its quarterly earnings on Monday, 2025-1...
11-01 03:03
Astronics Announces New $300 Million Credit Facility
An update from Astronics ( ($ATRO) ) is now available. On October 22, 2025, Ast...
10-23 04:51
美股大行评级 | 贝莱德、花旗、摩根大通、富国银行均获上调目标价！汇丰上调超微公司目标价升至310美元
今日重点评级关注：Roth Capital：维持Cingulate"买入"评级，目标价从10美元升至17美元；JMP证券：维持BioCryst Pharma"跑赢大市"评级，目标价从17美元升至27美元
10-16 10:43
